Additional file 3: of A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis

Figure S1. Frequency of stool hardness during treatment (Bristol Stool Chart scores). (PDF 1081 kb)